The Brazilian Society of Rheumatology recommendations on investigation and diagnosis of systemic autoimmune myopathies-Reference-Cited by-同舟云学术

The Brazilian Society of Rheumatology recommendations on investigation and diagnosis of systemic autoimmune myopathies

Published:2019-10-10 Issue:1 Volume:59 Page:
ISSN:2523-3106
Container-title:Advances in Rheumatology
language:en
Short-container-title:Adv Rheumatol

Author:

de Souza Fernando Henrique Carlos,de Araújo Daniel Brito,Vilela Verônica Silva,Simões Ricardo Santos,Bernardo Wanderley Marques,Frank Thais Amanda,da Cunha Bernardo Matos,Shinjo Samuel Katsuyuki

Abstract

Abstract Background This research is recommended by the Myopathy Committee of the Brazilian Society of Rheumatology for the investigation and diagnosis of systemic autoimmune myopathies. Body A systematic literature review was performed in the Embase, Medline (PubMed) and Cochrane databases, including studies published until October 2018. PRISMA was used for the review, and the articles were evaluated, based on the Oxford levels of evidence. Ten recommendations were developed addressing different aspects of systemic autoimmune myopathy investigation and diagnosis. Conclusions The European League Against Rheumatism/ American College of Rheumatology (EULAR/ACR) classification stands out for the diagnosis of systemic autoimmune myopathies. Muscular biopsy is essential, aided by muscular magnetic resonance images and electroneuromyography in complementary research. Analysis of the factors related to prognosis with the evaluation of extramuscular manifestations, and comorbidities and intense investigation regarding differential diagnoses are mandatory.

Funder

Sociedade Brasileira de Reumatologia

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Link

http://link.springer.com/content/pdf/10.1186/s42358-019-0085-5.pdf

Reference117 articles.

1. Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet. 2008;371:201–12.

2. Lundberg IE, Tjamlund A, Bottai M, Pikington C, de Visser M, Alfredson L, et al. 2017 European league against rheumatism / American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheum. 2017;69:2271–82.

3. Dalakas MC. Inflammatory muscle diseases. N Engl J Med. 2015;372:1734–47.

4. Lundberg IE, Miller FW, Tjärnlund A, Bottai M. Diagnosis and classification of idiopathic inflammatory myopathies. J Intern Med. 2016;280:39–51.

5. Iberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies;Clinical Rheumatology;2022-07-11

2. Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis;Rheumatology;2021-07-24

3. Treatment options from bench to bedside for adult dermatomyositis;Expert Opinion on Orphan Drugs;2020-03-03